home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Post navigation
Previous Post
Previous
Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl
Next Post
Next
Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates